Table 8.

Result of CSNI doses with 1% compounded budesonide drops.

Budesonide doses		Treatment cycle with 1% budesonide						Test	p-Value
		1000 µg		500 µg		Total
		n = 149		n = 143		n = 292
Treatment time (days)	M/SD	161.7	136.3	162.9	837.0	162.3	114.6	T	0.95
Subjective improvement	n (%)	61	84.7	53	80.3	114	82.6	Chi	0.49
Pre-treatment SNOT-22	M/SD	30.7	23.1	32.6	22.1	31.6	22.7	T	0.63
Post-treatment SNOT-22	M/SD	27.0	23.9	32.2	22.3	29.5	23.4	T	0.19
		Pre-post T	0.06	Pre-post T	0.43	Pre-post T	0.10
Pre-treatment total LKES	M/SD	5.5	2.5	4.8	3.4	5.2	3.0	T	0.20
Post-treatment total LKES	M/SD	4.8	2.9	4.3	3.4	4.6	3.2	T	0.35
		Pre-post T	0.03a	Pre-post T	0.08	Pre-post T	0.009a
Adverse events	n (%)	0	0.0	0	0.0	0	0.0	Fisher	1.00
Exacerbations	n (%)	5	6.9	6	9.1	11	8.0	Chi	0.64
Need for subsequent surgery	n (%)	5	6.9	6	9.1	11	8.0	Chi	0.64

Chi, Chi-square test; CSNI, corticosteroid nasal irrigation; Fisher, Fisher exact test; M, mean; SD, standard deviation; n, number; %, percentage; LKES, Lund–Kennedy endoscopic score; SNOT-22 (BR), SinoNasal Outcome Test-22 in Brazilian Portuguese; T, T-test.

^ap < 0.05.